Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9648]

Apalutamide plus ADT improves surgical outcomes in high-risk prostate cancer

Dr Adam Kibel - Dana-Farber Cancer Institute, Boston, USA

Apalutamide plus ADT improves surgical outcomes in high-risk prostate cancer ( Dr Adam Kibel - Dana-Farber Cancer Institute, Boston, USA )

Abemaciclib shows benefit in dedifferentiated liposarcoma

Dr Mark Dickson - Memorial Sloan Kettering Cancer Center, New York, USA

Abemaciclib shows benefit in dedifferentiated liposarcoma ( Dr Mark Dickson - Memorial Sloan Kettering Cancer Center, New York, USA )

Adjuvant selpercatinib reduces recurrence in RET-positive lung cancer

Dr Jonathan W. Goldman - University of California Los Angeles, Los Angeles, USA

Adjuvant selpercatinib reduces recurrence in RET-positive lung cancer ( Dr Jonathan W. Goldman - University of California Los Angeles, Los Angeles, USA )

Low-dose pembrolizumab plus chemotherapy improves survival and expands access...

Dr Nandini Menon - Tata Memorial Centre, Mumbai, India

Low-dose pembrolizumab plus chemotherapy improves survival and expands access in advanced NSCLC ( Dr Nandini Menon - Tata Memorial Centre, Mumbai, India )

ASCO 2026: Latest updates in mRCC

Dr Toni Choueiri, Prof Viktor Grünwald, Dr Martin Voss and Prof Jens Bedke

ASCO 2026: Latest updates in mRCC ( Dr Toni Choueiri, Prof Viktor Grünwald, Dr Martin Voss and Prof Jens Bedke )

Darolutamide shows less cognitive decline than enzalutamide in advanced...

Dr Alicia Morgans - Dana-Farber Cancer Institute, Boston, USA

Darolutamide shows less cognitive decline than enzalutamide in advanced prostate cancer ( Dr Alicia Morgans - Dana-Farber Cancer Institute, Boston, USA )

Tafasitamab plus lenalidomide and R-CHOP delays disease progression in...

Dr Georg Lenz - University Hospital Münster, Münster, Germany

Tafasitamab plus lenalidomide and R-CHOP delays disease progression in aggressive B-cell lymphomas ( Dr Georg Lenz - University Hospital Münster, Münster, Germany )

Adagloxad simolenin plus OBI-821 shows no survival benefit compared to standard...

Dr Hope Rugo - City of Hope, Duarte, USA

Adagloxad simolenin plus OBI-821 shows no survival benefit compared to standard of care in triple-negative breast cancer ( Dr Hope Rugo - City of Hope, Duarte, USA )

Neoadjuvant chemoradiotherapy plus sintilimab improves pCR in resectable...

Dr Xue-Feng Leng - Sichuan Cancer Hospital & Institute, Chengdu, China

Neoadjuvant chemoradiotherapy plus sintilimab improves pCR in resectable locally advanced oesophageal squamous cell carcinoma ( Dr Xue-Feng Leng - Sichuan Cancer Hospital & Institute, Chengdu, China )

Omission of axillary lymph node dissection reduces arm morbidity without...

Dr Jana de Boniface - Capio St. Göran's Hospital, Stockholm, Sweden

Omission of axillary lymph node dissection reduces arm morbidity without compromising survival in select breast cancer cases ( Dr Jana de Boniface - Capio St. Göran's Hospital, Stockholm, Sweden )

ASCO 2026: Breast cancer overview

Dr Hope Rugo - City of Hope, Duarte, USA

ASCO 2026: Breast cancer overview ( Dr Hope Rugo - City of Hope, Duarte, USA )

Bezuclastinib sunitinib combo shows promise in second-line GIST treatment

Dr Andrew J. Wagner - Dana-Farber Cancer Institute, Boston, USA

Bezuclastinib sunitinib combo shows promise in second-line GIST treatment ( Dr Andrew J. Wagner - Dana-Farber Cancer Institute, Boston, USA )

More from ecancer